{ "ok": true, "cik": "1938046", "ticker": "MGRX", "name": "Mangoceuticals, Inc.", "filings": [ { "form": "8-K", "filed": "2026-10-01", "items": [ "1.01 Entry into a Material Definitive Agreement", "2.01 Completion of Acquisition or Disposition of Assets", "3.02 Unregistered Sales of Equity Securities", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226045341/0001493152-26-045341-index.htm" }, { "form": "8-K", "filed": "2026-08-21", "items": [ "1.02 Termination of a Material Definitive Agreement", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226039724/0001493152-26-039724-index.htm" }, { "form": "10-Q", "filed": "2026-08-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226037873/0001493152-26-037873-index.htm" }, { "form": "8-K", "filed": "2026-08-04", "items": [ "8.01 Other Events", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226035993/0001493152-26-035993-index.htm" }, { "form": "8-K", "filed": "2026-07-30", "items": [ "1.01 Entry into a Material Definitive Agreement", "5.02 Departure or Election of Directors; Appointment of Officers", "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226035323/0001493152-26-035323-index.htm" }, { "form": "8-K", "filed": "2026-07-02", "items": [ "1.01 Entry into a Material Definitive Agreement", "3.02 Unregistered Sales of Equity Securities", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226031917/0001493152-26-031917-index.htm" } ], "events12m": 15, "healthWatch": { "window": "last 12 months", "since": "2025-10-02", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226014360/0001493152-26-014360-index.htm" } }, { "code": "3.01", "label": "Exchange listing notice or transfer", "count": 1, "latest": { "filed": "2026-02-06", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226005587/0001493152-26-005587-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-05-15", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226023883/0001493152-26-023883-index.htm" } }, { "code": "5.02", "label": "Director or officer change", "count": 3, "latest": { "filed": "2026-07-30", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226035323/0001493152-26-035323-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001938046.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1938046" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets and no trading recommendations.", "edgar": "🫧 Edgar looked up Mangoceuticals, Inc. ($MGRX). Last filing: 8-K (1.01 Entry into a Material Definitive Agreement), 2026-10-01. 15 event filings (8-K) in the past twelve months.", "auditor": { "changes": [], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 456021, "revenueGrowth1y": -0.25955351184416264, "revenueGrowthPerYear": 2.707678984892721, "yearsOfData": 4, "operatingMargin": -39.5428039498181, "operatingMarginPrior": -12.944215771758138, "netMargin": -45.26864990866649, "operatingCashFlow": -5850255, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 1486338, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2022-12-31", "revenue": 8939 }, { "fiscalYearEnd": "2023-12-31", "revenue": 731493 }, { "fiscalYearEnd": "2024-12-31", "revenue": 615873 }, { "fiscalYearEnd": "2025-12-31", "revenue": 456021 } ], "totalEquity": 15200547, "totalAssets": 16089573, "equityRatio": 0.9447452085894387, "returnOnEquity": -1.3580731667090664, "dividendsPaid": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "earningsPerShare": -2.17, "sharesOutstanding": 10071609, "bookValuePerShare": 1.5092471322109506, "revenuePerShare": 0.0452778697028449, "range80": { "low": 594163.5169453637, "high": 1664650.8870991755, "baseline": 1014472.1010952308, "n": 2483, "band": "b000", "bandLabel": "under $50M", "method": "v4.1", "credibility": 0.25, "growthYears": 2, "ownVolatility": 0.09083142616433632, "classVolatility": 0.3000583276631395, "volatility": 0.2637969616859941 }, "ifPaceHeld": { "low": 594163.5169453637, "high": 1664650.8870991755 } }, "edgarette": "🔖 Exposure: revenue $456K (FY2025). Experience: revenue down 26.0% on the year, up 270.8% a year over 3 years; operating margin -3954.3%, down from -1294.4%. Soundness: equity 94.5% of assets, return on equity -135.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $594K and $1.7M next year (method v4.1: its own 2-year record of growth weighed at 25% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $554K to $1.8M. A statistical range, not company guidance. Against peers (54 filers, $50M+ revenue, its industry group): operating margin -3954.3% against a 2.0% median; growth -26.0% against 13.0%.", "peers": { "sic": 8090, "sicDescription": "Services-Misc Health & Allied Services, NEC", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "summary": "Mangoceuticals (MGRX) saw revenue fall 26.0% in FY2025 to $0 million, operating margin -3954% against a 2.0% median for services-misc health & allied services, nec, equity 94.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
Mangoceuticals, Inc. against its own record and its peers
Operating marginPeer median 2.0%-3954.3%Revenue, on the yearPeer median 13.0%-26.0%Equity of assetsPeer median 44.2%94.5%Return on equityPeer median 1.6%-135.8%Gold tick: the median of 49–59 peers with $50M+ revenue in services-misc health & allied services, nec
", "chartHorizon": null, "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v4", "byYear": {}, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-02T14:03:49.262Z", "hash": "0d80ca6f1ce58f89", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Mangoceuticals (MGRX) saw revenue fall 26.0% in FY2025 to $0 million, operating margin -3954% against a 2.0% median for services-misc health & allied services, nec, equity 94.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 456021, "totalDebt": null, "cash": 1486338 }, "experience": { "revenueGrowth1y": -0.25955351184416264, "revenueGrowthPerYear": 2.707678984892721, "operatingMargin": -39.5428039498181, "operatingMarginPrior": -12.944215771758138, "netMargin": -45.26864990866649, "freeCashFlow": null }, "soundness": { "equityRatio": 0.9447452085894387, "returnOnEquity": -1.3580731667090664, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8090, "sicDescription": "Services-Misc Health & Allied Services, NEC", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "credibility": { "auditedYears": 4, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": null }, "healthWatch": { "window": "last 12 months", "since": "2025-10-02", "signals": [ { "code": "NT 10-K", "label": "Late annual report notice", "count": 1, "latest": { "filed": "2026-03-31", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226014360/0001493152-26-014360-index.htm" } }, { "code": "3.01", "label": "Exchange listing notice or transfer", "count": 1, "latest": { "filed": "2026-02-06", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226005587/0001493152-26-005587-index.htm" } }, { "code": "NT 10-Q", "label": "Late quarterly report notice", "count": 1, "latest": { "filed": "2026-05-15", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226023883/0001493152-26-023883-index.htm" } }, { "code": "5.02", "label": "Director or officer change", "count": 3, "latest": { "filed": "2026-07-30", "url": "https://www.sec.gov/Archives/edgar/data/1938046/000149315226035323/0001493152-26-035323-index.htm" } } ], "note": "Events the company itself filed with the SEC, most serious first. Shown beside the figures; they do not change the range or its receipt." }, "range": { "low": 594163.5169453637, "high": 1664650.8870991755, "baseline": 1014472.1010952308, "coverage": 0.8, "method": "v4.1", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); width = the company's own volatility of yearly growth, credibility-weighted against its size class (Buhlmann), scaled to the 80% target on 2023 and tested on 2024", "calibratedOn": { "companyYears": 2483, "sizeBand": "under $50M", "fitYears": [ 2018, 2022 ], "tuneYear": 2023, "testYear": 2024, "coverageOnTestYear": 0.8341, "coverageAllYears": 0.6904374799277399, "stressCoverageAllYears": 0.819004992974709, "outcomeYears": [ 2019, 2025 ] }, "credibility": { "weightOnOwnRecord": 0.25, "growthYears": 2, "ownVolatility": 0.09083142616433632, "classVolatility": 0.3000583276631395, "pricedVolatility": 0.2637969616859941, "k": 3 }, "stress": { "low": 553635.6404557119, "high": 1790900.798279871, "basis": "the same range with widths set to hold 80% across 2018-2023, pandemic years included" }, "kind": "a statistical range, not company guidance; no view on the share price", "track": { "backtest": { "tests": 0, "hits": 0, "rate": null, "method": "v4", "byYear": {}, "note": "hindsight: the same credibility-weighted range on the company's own past years. Years 2018-2023 were used to fit or tune the method, so only 2025 outcomes are fully out of sample." }, "registry": { "logged": "2026-10-02T14:03:49.262Z", "hash": "0d80ca6f1ce58f89", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001938046.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1938046" }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" }, { "key": "cash", "text": "operating cash flow was negative (-$5.9M in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±47%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -5850255, "investing": null, "financing": 7270855, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2022-12-31", "operating": -1346518, "free": -1389620 }, { "fiscalYearEnd": "2023-12-31", "operating": -6997375, "free": -7000894 }, { "fiscalYearEnd": "2024-12-31", "operating": -4863776, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -5850255, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 1486338, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 16089573, "ladder": null, "currentRatio": 1.74, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same range method applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so.", "healthWatch": "Distress-type events the company filed in the last 12 months (late-filing notices; 8-K items 1.03, 3.01, 2.04, 4.02, 4.01, 2.05, 2.06, 1.05, 5.02), each with its count and newest filing. Display only: they do not change the range or its receipt." }, "speedCash": null, "harbor": { "signs": [ { "key": "warning", "text": "filed late annual report notice, late quarterly report notice in the last 12 months" }, { "key": "cash", "text": "operating cash flow was negative (-$5.9M in FY2025)" }, { "key": "range", "text": "revenue is hard to predict: its 80% range is ±47%" } ], "rule": "Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider.", "level": 3, "name": "Old boat", "plain": "three warning signs" }, "cashFlow": { "fiscalYearEnd": "2025-12-31", "operating": -5850255, "investing": null, "financing": 7270855, "capitalSpending": null, "free": null, "trend": [ { "fiscalYearEnd": "2022-12-31", "operating": -1346518, "free": -1389620 }, { "fiscalYearEnd": "2023-12-31", "operating": -6997375, "free": -7000894 }, { "fiscalYearEnd": "2024-12-31", "operating": -4863776, "free": null }, { "fiscalYearEnd": "2025-12-31", "operating": -5850255, "free": null } ], "note": "Annual, as filed in 10-K cash flow statements; negative investing/financing = cash going out (capital spending, buybacks, dividends, debt repaid)." }, "investments": { "fiscalYearEnd": "2025-12-31", "cash": 1486338, "shortTerm": null, "longTerm": null, "equityHoldings": null, "totalAssets": 16089573, "ladder": null, "currentRatio": 1.74, "unrealizedGain": null, "unrealizedLoss": null, "note": "Balance-sheet cash and investment securities at fiscal year end, as filed; short-term = due or saleable within a year. Insurers and banks hold most of their book here." } }